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http:WHAT THIS PAPER ADDS
This study demonstrates that, even though uncommon, open surgical secondary procedures after thoracic
endovascular aortic repair can be performed by a team experienced in the management of diseases of the
thoracic aorta and achieve a low mortality rate, despite the precarious preoperative conditions and complex
aortic pathologies of patients. Furthermore, most failures can be prevented.Objectives: Improved outcomes of thoracic endovascular aortic repair (TEVAR) compared with open repair have
changed the therapeutic paradigm of thoracic aortic lesions. As the number of TEVAR survivors has grown,
reports of complications have similarly increased. Although secondary endovascular rescue measures are often
undertaken, patients with serious complications are often converted, ultimately, to open repair. The aim of this
study was to assess causes and midterm results of open surgical secondary procedures after thoracic
endovascular aortic repair.
Methods: A total of 236 patients underwent TEVAR. Fourteen of these patients required open repair because of
six aortobronchial ﬁstulas, four retrograde type A dissections, two aneurysm enlargement without endoleak, one
thoracic stent-graft collapse, and one aortoesophageal ﬁstula. Eight (57.1%) patients underwent surgical repair
using cardiopulmonary bypass. Six stent-grafts were totally removed, and eight stent-grafts were left in situ. Four
patients underwent supracoronary ascending aorta replacement, and one an extensive replacement of the aortic
arch through sternotomy. Three patients had descending aortic replacement through left thoracotomy combined
with a total esophagectomy in one case. One patient was treated by ligation of the aortic arch, ascending to
supraceliac abdominal aorta bypass and stent-graft explantation. One patient was treated by exclusion bypass of
the descending thoracic aorta. Pulmonary resection and large pleural or intercostal muscle ﬂap interposition to
wrap the stent-graft left in situ was done in four cases of aortobronchial ﬁstula.
Results: All patients survived the surgical procedure. Ten patients (71%) had an uneventful postoperative course.
There were two in-hospital deaths (14.3%). Both died from multi-organ failure in the early postoperative course
after surgical repair of a stent-graft infection and an aortoesophageal ﬁstula. One patient suffered a deﬁnitive
paraplegia and a secondary aortoesophageal ﬁstula requiring reoperation for esophageal repair. One patient,
treated by pulmonary resection and ﬂap interposition to wrap the stent-graft, underwent stent-graft explantation
and in situ descending aortic replacement because of stent-graft reinfection. Actuarial survival was 87.7% after a
mean follow-up of 26.3 months (range 9e72 months).
Conclusions: Complications or prevention of complications after TEVAR either due to device failure or adverse
events may require conversion to open repair or additional open surgical procedure. Open repair can be
performed by a team experienced in management of diseases of the thoracic aorta and a low mortality rate
achieved despite the precarious preoperative conditions and complex aortic pathologies of patients.
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The superior outcome of thoracic endovascular aortic repair
(TEVAR) compared with open repair has changed the
therapeutic paradigm for thoracic aortic lesions. The long-
term durability of TEVAR however remains a concern. The
potential for adverse events related to stent-graft infection,
endoleak, aortobronchial or aortoesophageal ﬁstula, retro-
grade dissection, and stent-graft failure mandate lifelong
surveillance.
668 L. Canaud et al.As the number of TEVAR survivors has grown, reports of
complications have similarly increased.1e5 Although rein-
tervention is often endovascular, patients with serious
complications are often ultimately converted to open
repair.1
The incidence of open repair after TEVAR ranges from
2.2% to 7.2% at experienced centers,1e4 and the associated
morbidity and mortality can be signiﬁcantly higher than
with primary open repair. The presence of the stent-graft is
often associated with a technically more challenging surgi-
cal exposure and the patients are often physiologically
highly compromised. The development of strategies to
manage such complex conditions is absolutely imperative.
The aim of this article is to present our experience of
open surgical secondary procedures after TEVAR.METHODS
Between 2002 and 2012 a total of 236 patients underwent
thoracic aortic stenting at our institution, and of these 14
(5.9%, 9 male, mean age 67.3 years old, range 22e75 years)
consecutive patients required subsequent open surgical
procedures. Surgical strategies, perioperative and medium-
term results were analyzed.Retrograde type A dissection
Four patients developed retrograde type A dissection
(RTAD) after exclusion of aneurysms of the aortic arch (2
men, mean age 67.7 years, range 58e77 years).
Indication for TEVAR was degenerative aneurysm (6 cm
or larger) in all cases, with one ruptured at the time of
treatment. The proximal landing zone was zone 0 in three
cases and zone 1 in the remaining patients according to the
aortic arch map proposed by Ishimaru.6 For zone 0 patients,
diameters of the ascending aorta were 39, 42, and 40 mm.
For zone 0 patients, concominant arch vessel debranching
was performed via median sternotomy. Sequential reim-
plantation of the aortic arch vessels was performed using
Dacron grafts sutured to the native ascending aorta just
above the sinotubular junction. For zone 1 patients, hemi-
aortic arch debranching was performed by sequential
transposition of the left common carotid and subclavian
arteries via a cervicomanubriotomy.
Endovascular exclusion was achieved in the same oper-
ative session using three different stent-graft systems:
Valiant stent-graft (Medtronic Inc, Minneapolis, MN, USA)
in two cases, TAG stent-graft (WL Gore & Associates, Inc,
Flagstaff, AZ, USA) in one case, and Conformable-TAG in one
case. Ballooning of the stent-graft was systematically
performed.
Aortic arch malformation was present in three patients:
 right aortic arch with a retroesophageal course in one
case
 right aberrant retroesophageal subclavian artery in one
case
 bovine aortic arch in one case.Ascending aortic aneurysm, which did not require
ascending aorta replacement, was present in three of the
patients.
Only one patient was symptomatic (chest pain) and the
RTAD was identiﬁed on postoperative day 4. The three
remaining patients were completely asymptomatic, and the
RTAD was revealed on the routine postoperative computed
tomography (CT) scan performed pre-discharge on day 7.
Full cardiopulmonary bypass was used in all patients.
Cerebral protection was achieved by means of selective
antegrade perfusion via the arterial cannula introduced in
the debranching graft in cases of total aortic arch
debranching or via the right axillary artery in the case of
hemi-arch debranching. During circulatory arrest with mild
hypothermia (vesicle temperature at 28 C), the ascending
aorta was transected. Specimens from the aorta were
analyzed and there were no signs of aortic disorders. The
proximal covered or uncovered spring of the stent-graft was
removed. The distal part of the graft was sutured to the
proximal end of the stent-graft. Distal perfusion was re-
established through an inﬂated Foley catheter placed in
the distal aortic arch. The supracoronary ascending aorta
was replaced with a knitted Dacron graft (C. R. Bard,
Haverhill, PA, USA). The graft used for debranching to the
supra-aortic trunks was reimplantated for patients treated
initially by total aortic arch debranching. For the patient
treated by hemi-arch debranching, the brachiocephalic
trunk was bypassed from the ascending aortic graft. The
proximal anastomosis was performed at the level of the
sinotubular junction in three cases. In one case, a Bentall
procedure was required.Aortoesophageal ﬁstula
An 86-year-old woman had undergone endovascular repair
of a ruptured descending thoracic aortic aneurysm 18
months previously. She was admitted to our hospital for
backache. An emergency CT scan disclosed an aortoeso-
phageal ﬁstula. Via a left thoracotomy, on femoro-femoral
cardiopulmonary bypass, the stent-graft was explanted
and an interposition aortic tube graft repair (silver-coated
polyester graft) of the descending thoracic aorta was per-
formed. The area of esophageal disruption exceeded 3 cm in
length, so no attempts were made to reconstruct the
esophagus. A total esophagectomy was performed in the
same operation, stapling the esophagus at the level of the
diaphragm.Thoracic stent-graft collapse
A 27-year-old patient presented with a traumatic rupture of
the thoracic aorta and was treated by emergency TEVAR.
Stent-graft collapse was observed 30 days after implanta-
tion by a pseudocoarctation syndrome leading to functional
renal failure. Via a left thoracotomy, on femoro-femoral
cardiopulmonary bypass, the stent-graft was explanted
and a descending thoracic aneurysm repair was performed
using an interposition tube graft.
Figure 1. Aneurysm enlargement without endoleak with a right-sided descending thoracic aorta, treated by exclusion-bypass of the
descending thoracic aorta (B, C) via a double left thoracotomy (A).
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Two male patients (75 and 58 years old) underwent TEVAR
for descending thoracic aortic aneurysms greater than 6 cm
in diameter. After more than 18 months of follow-up,
routine CT scans demonstrated aneurysm enlargement
without evident endoleak. In one case, via a left thoracot-
omy, on femoro-femoral cardiopulmonary bypass, the stent-
graft was explanted and a descending thoracic aneurysm
repair was performed using an interposition tube graft. The
second patient, with a right-sided descending thoracic
aorta, was treated by exclusion bypass of the descending
thoracic aorta via a double left thoracotomy (Fig. 1).Aortobronchial ﬁstula
Primary aortobronchial ﬁstula (n [ 2). Two females (75
and 84 years old) underwent emergent TEVAR for primary
aortobronchial ﬁstula. One of them suffered from a miliary
tuberculosis. Two different stent-grafts were used:
Conformable-TAG in one case and Valiant stent-graft in the
other. During the same procedure, in one case, a left upper
lobectomy was performed. For the other case, a left lower
lobectomy was performed as a staged procedure. For both
patients aortic debridement and coverage of the stent-graft
was achieved using pleural ﬂaps. One patient received a 6-
week course of broad-spectrum intravenous antibiotics
followed by lifelong oral antibiotic suppression. The patient
that suffered from miliary tuberculosis received prolonged
(18 months) antituberculous drug therapy (isoniazid,
rifampin, and ethambutol).
Aortobronchial ﬁstula after TEVAR (n [ 3). Three males
(mean age 70.7 years old, range 58e84 years) underwent
surgical conversion for a secondary aortobronchial ﬁstula
after TEVAR. The initial indication for TEVAR was degener-
ative descending thoracic aortic aneurysm (n ¼ 1), aortic
arch aneurysm (n ¼ 1), and dissecting descending thoracic
aortic aneurysm (n ¼ 1). The proximal landing zone was
zone 0 in one patient and zone 3 in two patients. Twodifferent stent-grafts were used: Talent stent-graft (n ¼ 1)
and Valiant stent-graft (n ¼ 2).
In two cases, via a left thoracotomy, a pulmonary seg-
mentectomy was performed and coverage of the stent-graft
was carried out using a pleural ﬂap in one case and using
the serratus muscle in the other (Fig. 2).
In one case of aortobronchial ﬁstula after zone
0 debranching and endovascular aortic arch exclusion, full
cardiopulmonary bypass was performed. Cerebral pro-
tection was achieved by means of selective antegrade
perfusion via the arterial cannula introduced in the
debranching graft. During circulatory arrest with mild
hypothermia, the ascending aorta was transected. The
stent-graft was removed and the aortic arch was replaced
using a silver-coated graft. Atypical resection of the lung
was performed during the same operative time and the
graft was covered with a pleural ﬂap. All the patients
received a 6-week course of broad-spectrum intravenous
antibiotics followed by lifelong oral antibiotic
suppression.
Aortobronchial ﬁstula after open aortic surgery treated by
TEVAR (n [ 1). A 75-year-old male, initially treated by
TEVAR alone (Tag stent-graft) for an aortobronchial ﬁstula
after open aortic surgery was readmitted 2 months after
endovascular repair for a thoracic stent-graft infection. The
patient underwent thoracic aortic ligation, extra-anatomic
bypass (ascending to supraceliac abdominal aorta bypass),
and stent-graft explantation.RESULTS (TABLE 1)
All patients survived the surgical procedure. Ten patients
(71%) had an uneventful postoperative course. There were
two in-hospital deaths (14.3%). Both of them died from
multi-organ failure in the early postoperative course after
surgical repair of thoracic stent-graft infection and aortoe-
sophageal ﬁstula after TEVAR. Actuarial survival was 87.7%
after a mean follow-up of 26.3 months (range 9e72
months).
Figure 2. Aortobronchial ﬁstula after TEVAR: via a left thoracotomy a pulmonary segmentectomy was performed, the stent-graft was left in
place (A) and coverage of the stent-graft was performed using the serratus muscle (B).
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The postoperative course was uneventful for the four pa-
tients, except for a case of postoperative sternitis success-
fully treated by prolonged intravenous antibiotic therapy.
All the patients are doing well after a mean follow-up of 33
months.
Aortoesophageal ﬁstula
The patient died of multi-organ failure 5 days after surgery.
Thoracic stent-graft collapse
The postoperative course was uneventful. The patient was
discharged on postoperative day 8 and is doing well after a
follow-up of 63 months.
Aneurysm enlargement without endoleak
The postoperative course was uneventful for the patient
treated by stent-graft explantation and descending thoracic
aneurysm repair. The patient is doing well after a follow-up
of 17 months.
The second patient, treated by exclusion bypass of the
descending thoracic aorta, developed paraplegia and acute
respiratory distress syndrome. He was readmitted 8 months
after surgical conversion for a secondary aortoesophageal
ﬁstula requiring redo thoracotomy and successful direct
esophageal repair. The patient is doing well after a follow-up
of 12 months.
Aortobronchial ﬁstula
Primary aortobronchial ﬁstula (n [ 2). The postoperative
course was uneventful for both patients. After a mean
follow-up of 22 months, both are asymptomatic and an 18-month post-procedure positron emission tomography scan
was unremarkable.
Aortobronchial ﬁstula after TEVAR (n [ 3). In one case,
treated by pulmonary segmentectomy and coverage of the
stent-graft using the serratus muscle, the patient was
readmitted 4 months after surgical conversion for severe
mediastinitis, revealing thoracic stent-graft infection. Via a
left redo thoracotomy, on femoro-femoral cardiopulmonary
bypass, the stent-graft was explanted and a descending
thoracic aneurysm repair was performed using a silver-
coated tube graft (Fig. 3). The postoperative course was
uneventful and after a follow-up of 6 months, the patient is
asymptomatic and a 6-month post-procedure CT scan was
without abnormalities.
For the two remaining patients, the postoperative course
was uneventful. After a mean follow-up of 13 months, pa-
tients are asymptomatic and a 12-month post-procedure CT
scan was unremarkable.
Aortobronchial ﬁstula after open aortic surgery treated by
TEVAR (n [ 1). The patient treated by thoracic aortic
ligation and extra-anatomic bypass died of multi-organ
failure 7 days after surgery.DISCUSSION
The incidence of TEVAR failure requiring open surgical
correction or additional open surgical procedures ranges
from 2.2% to 7.2%.2e4 Growing experience in TEVAR
currently helps physicians to identify clinical or anatomical
situations associated with a high risk of stent-graft failure.7
One of the most feared complications of this procedure is
RTAD, which has a low incidence (1.3e6.8%)8 but high
Table 1. Demographic data and survey of open surgical secondary procedures after thoracic endovascular aortic repair.
Patient Age Sex Aortic pathology Stent graft Time to conversion Conversion Outcome
1 M 59 Ruptured aortic arch
aneurysm
Valiant Retrograde
type A dissection
6 d Bentall procedure Discharged
2 F 76 Aortic arch aneurysm Tag Retrograde
type A dissection
4 d Supracoronary ascending
aorta replacement
Discharged
3 F 60 Aortic arch aneurysm C-Tag Retrograde
type A dissection
8 d Supracoronary ascending
aorta replacement
Discharged
4 M 75 Aortic arch aneurysm Valiant Retrograde
type A dissection
7 d Supracoronary ascending
aorta replacement
Discharged
5 F 86 Ruptured TAA Tag Aortoesophageal
ﬁstula
18 months Descending aortic
replacement and
esopahgectomy
Died
6 M 27 Traumatic transection
of the aorta
Tag Stent-graft
collapse
30 d Descending aortic
replacement
Discharged
7 M 75 Descending thoracic
aneurysm
Valiant
and
Tag
Aneurysm
enlargement
20 months Descending aortic
replacement
Discharged
8 M 58 Descending thoracic
aneurysm
C-Tag Aneurysm
enlargement
12 months Exclusion-bypass of the
descending thoracic aorta
Paraplegia
Acute respiratory
distress syndrome
Aortoesophageal ﬁstula
9 F 75 Primary aortobronchial
ﬁstulae
C-Tag Prevention of
stent-graft infection
Intraoperative Left upper lobectomy
Aortic debridement
Pleural ﬂap
Discharged
10 F 84 Primary aortobronchial
ﬁstulae
Valiant Prevention of
stent-graft infection
7 d Left lower lobectomy
Aortic debridement
Pleural ﬂap
Discharged
11 M 58 Dissecting descending
thoracic aortic aneurysm
Valiant Secondary aortobronchial
ﬁstulae: after TEVAR
28 months Pulmonary segmentectomy
Aortic debridement
Pleural ﬂap
Discharged
12 M 84 Aortic arch aneurysm Talent Secondary aortobronchial
ﬁstulae: after TEVAR
11 months Aortic Arch replacement
Pleural ﬂap
Discharged
13 M 70 Degenerative descending
thoracic aortic aneurysm
Valiant Secondary aortobronchial
ﬁstulae: after TEVAR
13 months Pulmonary segmentectomy
Aortic debridement
Serratus muscle ﬂap
Stent-graft infection:
Descending aortic
replacement
14 M 75 Secondary aortobronchial
ﬁstulae: after TEVAR
Tag Stent-graft infection 60 d Ascending to supraceliac
abdominal aorta bypass
Died
Note. TAA ¼ thoracic aortic aneurysm; TEVAR ¼ Thoracic Endovascular Aortic Repair.
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Figure 3. Thoracic stent-graft infection after TEVAR for aortobronchial ﬁstula: the stent-graft was explanted and a descending thoracic
aneurysm repair was performed using a silver coated tube graft.
672 L. Canaud et al.mortality: 42.2% (n ¼ 20/48) in the largest cohort
reported.9
Several reports have investigated the underlying etiology
of this complication. Is RTAD a true complication of the
procedure (guidewire manipulation, stent-graft conﬁgura-
tion, stent-graft misalignment) or natural progression of the
disease itself? Most reports including a European multi-
centric registry9 and institutional reviews10,11 have stressed
the likely role of the proximal bare stent-graft conﬁguration.
The fragility of the aortic wall and disease progression is
likely to predispose to RTAD because most of the patients
reported in the literature were treated for an aortic
dissection, and, furthermore, most of them were treated in
an acute setting.9 Hata et al.12 had reported the results of
180 patients with acute type B dissection under best
medical treatment. Among them, four patients developed a
type A dissection. This incidence (2.2%) is quite similar to
the incidence of RTAD after TEVAR. As previously reported
by Williams et al.,10 we believe that an ascending aorta
diameter of >40 mm is another potential predictor of
RTAD. In our short series, aortic arch malformation can also
contribute to the development of RTAD: aortic arch mal-
formation was present in three of the patients. Other in-
vestigators have proposed balloon dilation of the stent-graft
to be associated with RTAD. Intimal tears could be caused
by application of the radial force of balloon angioplasty to
devices or directly to the aortic wall. Therefore, balloon
inﬂation should be avoided in most patients except for
those with evident type I endoleak. This complication can
also arise from wire and sheath manipulation in the aortic
arch during the endovascular procedure, which may cause
localized intimal tears in the fragile aortic wall. Particular
attention should be given to minimize manipulation of
guidewires and stent-graft systems in these at-risk patients.In a transcontinental registry, the incidence of RTAD has
been reported as up to 7.5% during zone 0 total
debranching.13 The risk of aortic side-clamping under pul-
satile ﬂow in development of iatrogenic type A dissection is
well-known during off-pump coronary artery bypass sur-
gery, especially in cases of increased ascending aortic
diameter. The treatment of choice is ascending and aortic
arch replacement with suturing of the vascular graft directly
to the stent-graft. Complete stent-graft explantation using
the “elephant trunk” technique has been infrequently per-
formed as an alternative strategy. Conservative manage-
ment has been proposed in a few cases with various
outcomes.14,15 Medical management can only be proposed
if patients have limited dissection (especially for those with
wire-induced wall injury), and if the patients remained
clinically stable under close follow-up.
Primary and secondary aortobronchial ﬁstulae are uni-
formly fatal if untreated and remain a formidable surgical
problem in older, high-risk patients with hemorrhagic shock
or sepsis. Despite advances in surgical technique, open
repair still has a high operative mortality, which may reach
41%.13 The perioperative outcomes of the endovascular
approach have demonstrated favorable outcomes.16 Con-
cerns about the risk of recurrence of the aortobronchial
ﬁstula or of infection of the stent-graft after endovascular
repair have been raised.17 TEVAR does nothing to address
the issue of the defect in the respiratory tract, leaving the
patients at risk of aortobronchial ﬁstula recurrence and/or
stent-graft infection. Our experience shows that the bron-
chial defect should be addressed. Direct contact between
the stent-graft and the pulmonary tissue should be avoided
to prevent further erosive damage. The concomitant repair
may entail primary repair or resection and anastomosis of
the bronchus and/or pulmonary resection with coverage of
European Journal of Vascular and Endovascular Surgery Volume 46 Issue 6 p. 667e674 December/2013 673the stent-graft using muscle or pleural ﬂaps. Another sur-
gical strategy is to consider TEVAR as a bridge therapy: in
young and ﬁt patients TEVAR is followed by a delayed du-
rable open repair when the patient has regained relative
physiological stability.18
Aortoesophageal ﬁstula after TEVAR is a rare complica-
tion, and is generally fatal without surgical intervention.
Open repair involves combined replacement or bypass of
the thoracic aorta with concomitant resection or repair of
involved esophagus. Despite signiﬁcant reﬁnement in sur-
gical techniques, the operative mortality of open aortoe-
sophageal ﬁstula repair ranges from 45.4% to 55%.19,20
Clearly, any strategy in this patient population needs to
be highly individualized given the risks of major thoracic
aortic surgery often in a hostile operative ﬁeld. The patient
should receive intensive medical support to correct anemia,
broad-spectrum antibiotics, including antifungal coverage,
and adequate nutritional replenishment. Once the patient
has clinically improved, the patient should be referred to
undergo open surgery as soon as possible: drainage and
primary repair or resection of the esophagus alone or
combined removal of the stent-graft and aortic recon-
struction. In certain patients who are moribund, surgical
intervention is clearly inappropriate. For this subgroup of
patients, a combination of aortic and esophageal stenting
has been advocated as treatment of this problem.21
Lately, cases of stent-graft collapse have been identiﬁed
with a high risk of complications and death.22 Stent-graft
collapse after TEVAR seems to be related to poor apposi-
tion of the stent grafts in a highly angulated aortic arch and/
or excessive stent-graft oversizing. In planning a treatment
strategy, assessment of aortic arch anatomy and appro-
priate choice of the device may prevent such a complica-
tion. Most of the cases have been reported with the TAG
device (WL Gore) when severely oversized and/or with
acute aortic arch angulation. However, the enhanced con-
formability of the last generation of thoracic stent-graft has
signiﬁcantly decreased the rate of stent-graft collapse.23,24
Several therapeutic options can be proposed: the stent-
graft can either be removed via an open thoracotomy or
be re-expanded by an endoluminal approach. Open repair
should be considered in cases of severely collapsed stent
graft and/or deemed at high risk of coverage of supra-aortic
trunks owing to a severely angulated aortic arch.
Progressive increase in aneurysm size without identiﬁable
endoleak is one of the major limitations of endovascular
treatment. Because of the progressive aneurysm enlarge-
ment, a surgical conversion is necessary to remove the
stent-graft and reconstruct the aorta. This failure of exclu-
sion likely represents the presence of pressurized aneurysm
or endotension.
Surgical repair of a failed thoracic stent-graft is a complex
procedure. Perioperative strategies, including selective
antegrade cerebral perfusion (in case of arch surgery) and
distal perfusion of the lower body enabled us to avoid
neurologic, myocardial, and visceral complications in these
complex aortic procedures. In our experience, prevention of
paraplegia is based on distal perfusion of the lower body,systematic left subclavian revascularization, and selective
preoperative lumbar drain placement in case of prior
abdominal aortic surgery or planned extensive aortic repair.
Evidence is growing that TEVAR for aortobronchial ﬁstula
and even more so for aortoesophageal ﬁstula does nothing
to address the issue of a defect in the respiratory or
digestive tract, leaving the patients at risk of ﬁstula recur-
rence. The concomitant repair may entail primary repair or
resection of lung or of the esophagus with coverage of the
stent-graft using muscle or pleural ﬂaps. Occasionally, an
extra-anatomic approach might be justiﬁed to avoid recur-
rent graft infection.
The main limitation of the present study is the retro-
spective nature of the study and the relatively small sample
size. Furthermore, this was a heterogeneous population of
patients with different characteristics and indications for
TEVAR.CONCLUSION
Although endovascular repair has revolutionized aortic
surgery, careful evaluation and selection for this approach
remain essential. As utilization of this technique increases,
the incidence of complications is increasing. Ongoing review
of such patients is beneﬁcial in elucidating the underlying
mechanisms leading to late conversion and selection of
patients in which this is most appropriate. Secondary con-
ventional surgical procedures after TEVAR can be performed
with relatively low perioperative risk, despite the technical
challenge and the precarious physiological status presented
by such patients.FUNDING
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